Timothy Wilkin, MD

Cornell UniversityNew York, New York - 10011 (212-746-7262) Cornell CRSNew York, New York - 10011 (212-746-7198) |
- CLINICAL TRIALS 2
- CONDITIONS2
- INTERVENTIONS5
- SINCE2009

Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir
November 2009 - July 2011

Chloroquine for Reducing Immune Activation in HIV- Infected Individuals
March 2009 - November 2012
Acquired Immunodeficiency Syndrome
HIV Infections
Placebo
Chloroquine
Dna + Hiv-Rad5 Vaccine
Art Intensification (Raltegravir)
Art Intensification (Maraviroc)



